
ã¯ã¯ãã³æ¥çš®åŸäžé±éã¯AIDSã¬ãã«ãŸã§ãªã³ãçãæžå°ãããnatureè«æã

ããã«ã¡ã¯å»åž«ïŒå»ççµæžãžã£ãŒããªã¹ãã®æ£®ç°ã§ãã
å æ¥ããã¡ãã®åç»ãèŠãŸããã
æ±äº¬å€§åŠã»å ç«åŠã®æ°ç°åææã«ããäžè¬åãã®ã³ããïŒã¯ã¯ãã³è§£èª¬ã§ãã
ãšãŠããããããããŠãããã倧äºãªããšãçãã ãããã§ãã®ã§ããã²ã芧é ãããã®ã§ããâŠã
ãšã¯èšã£ãŠããããªãé·ãã®ã§ç°¡åã«ãã€ã³ãïŒç¹ã«åŸåã®ã¯ã¯ãã³è«æè§£èª¬éšåïŒããŸãšããŸããšã以äžã®3ã€ã§ããããã
ã»ãªããmRAãå
ãã§ããLNPåç¬æ¥çš®ïŒïŒmRNAãå
¥ã£ãŠããªãã¯ã¯ãã³ïŒã§ãããªãã®å¹æãããã
ã»ã¯ã¯ãã³ã§IgAïŒæ°éææã®äž»èŠå
ç«ïŒã¯èªå°ãããªã
ã»ã¯ã¯ãã³æ¥ç𮿰æ¥åŸã¯ãªã³ãçãæžå°ããïŒïŒé±éã§æ»ãïŒ
ã©ããçµæ§ã³ã£ããã®å
容ã§ãããäžã§ãæåŸã®
ã»ã¯ã¯ãã³æ¥ç𮿰æ¥åŸã¯ãªã³ãçãæžå°ããïŒïŒé±éã§æ»ãïŒ
ã¯å人çã«éåžžã«é©ãã§ããã
ãšããããšã§ãã¿ã€ãã«éãä»åã¯ãã®ä»¶ã«ã€ããŠèšäºã«ããããšæããŸãã
ãšããã®ããåã¯ããªã³ãçæžå°ãã«ã¯èŠãæããããã®ã§ãã
ç ä¿®å»æä»£ãå ç«æå¶å€ã«ãããªã³ãçæžå°ããããµã€ãã¡ã¬ããŠã€ã«ã¹èºçãã«ããã£ãŠäº¡ããªã£ãŠããŸã£ãæ£è ããã®ããšãé®®æã«èŠããŠããããã§ãã
ãµã€ãã¡ã¬ããŠã€ã«ã¹ããã«ãã¹ãŠã€ã«ã¹ã¯å€ãã®äººãäœå ã«ä¿æããŠãããŠã€ã«ã¹ã§ãéåžžã®å ç«ãä¿æããŠãããšãã¯å ç«ã«æããããŠå šã害ããªããªãã®ã§ããããªã³ãçæžå°ãªã©ã®å ç«äœäžç¶æ ã«ãªããšçªç¶é¡ãåºãèŽæ»çãªç æ ã«é¥ã£ãŠããŸããŸãããããããæ¥åèŠææããšèšããããã®ã§ãã
ãã¡ããããµã€ãã¡ã¬ããŠã€ã«ã¹ãé¡ãåºããŠæ¥ããããããªå
ç«äœäžã¯éåžžã¯æ®ã©èŠãããŸããã
å
ç«æå¶å€ãæããå€ãHIVææãªã©ã®ç¹æ®ãªç¶æ³äžã§ã®ã¿èŠããããã®ã§ãã
ã§ããªããšãã®å ç«æå¶ç¶æ ïŒãªã³ãçæžå°ïŒããã¯ã¯ãã³æ¥çš®åŸã®1é±éã»ã©ãæ®ã©ã®æ¹ã«èŠããããšããããšãªã®ã§ãã
ããããã¡ãã®ã°ã©ãïŒæ°ç°å çããæç€ºãããã®ãã®ïŒ

æ¥æ¬èªéšåã¯æ°ç°å
çã远å ããããã®ã§ãããå
ããŒã¿ã¯ã2020幎ã®ãã®äžççç§åŠèªãnatureãã«æ²èŒãããè«æã§ãã
ïŒCOVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, Extended Data Fig. 3 ïŒ
ã¯ã¯ãã³æ¥çš®2æ¥åŸïŒDay 2ïŒã§å€§ãããªã³ãçãæžå°ãã8æ¥åŸïŒDay 8)ã§ã»ãŒå éãã«æ»ã£ãŠããŸãã
ãã®ãªã³ãçæžå°ã®çšåºŠã¯ããªãæ¿ãããã°ã©ãã§ã¯AIDSçºçã¬ãã«ãŸã§ã®æžå°ããäŸãŸã§èŠãããŠããŸããïŒæ°ç°å çãæç€ºã®éç¹ç·ãAIDSçºçã¬ãã«ïŒ
ãªããAIDSïŒåŸå€©æ§å ç«äžå šçå矀ïŒã¯HIVãŠã€ã«ã¹ææã«ãããã®ãæåã§ããå®ã¯ããã ãã§ãªããåŸå€©çïŒå 倩çã§ã¯ãªãïŒã«å ç«æ©èœãèããäœäžããç¶æ ã®ç·ç§°ã§ããHIV以å€ã§ãèµ·ããŸãã
ãã¡ããAIDSã¬ãã«ãŸã§ã®ãªã³ãçæžå°ã¯ããäžéšãªã®ãããããŸããã
ããããããŒã¿ãèŠããšã¯ã¯ãã³æ¥çš®è
åŸã®ãªã³ãçæžå°ã¯äŸå€ãªãå
šäŸã§çºçããŠããããã§ãããããæ¥çš®è
ã®å
šäŸã§ãªã³ãçãæžå°ããŠããŸãã°ãAIDSãªã©åœåãã®ç¶æ
ã«ãŸã§ã¯ãªããªããŠããéåžžã®ææçã«ææãããããªãïŒã§ãããã«æ²»ãïŒçšåºŠã®ããšãçºçããããïŒãšèããã®ãèªç¶ã ãšæããŸãã
ãããè£ä»ãããããªäºå®ã2ã€ãããŸãã
1ã€ã¯ãæ¥æ¬ã®å®éã®ã¯ã¯ãã³æ¥çš®ãšã³ããææã®é¢é£ã§ãã
å®ã¯æ¥æ¬ã®çããŒã¿ãèŠããšãã¯ã¯ãã³ãæã£ãçŽåŸã«ææãæ¡å€§ããŠããã®ã§ããïŒæææžå°ã§ã¯ãªãïŒïŒ
æãããŠãããå¶ç¶ã§ããããïŒ

https://medicalfacts.info/infect.rb?c=Japan&from=2022-01-01&to=2022-12-29&new_cases_smoothed_per_million=true&new_vaccinations_smoothed_per_million=true&two=true&l=ja&i=false
2ã€ç®ã¯ããã¡ã€ã¶ãŒãçºè¡šããã95ïŒ å¹æãããã®ãäžççå»åŠèªNEJMã®è«æã§ããå®ã¯ãããæ¥çš®åŸïŒé±éãŸã§ã¯ãæäœããŸã ç£çãããŠããªãããšããçç±ïŒã§å€ããé€å€ãããŠããã®ã§ããã€ãŸãã
ã»ã¯ã¯ãã³ãæ¥çš®ãã
ããâ
ã»æ¥çš®åŸ1é±éã¯ã»ãŒå
šå¡ã§ãªã³ãçãæžå°ããŠææçã«ãããããããªã£ã
ããâ
ã»ãã®ãã¡ã®äžéšã®äººãã³ããã«ææãã
ããâ
ã»ã§ããã®äººãã¡ã¯çµ±èšã§ã¯é€å€ãããã
ããâ
ã»ãã®çµæã95ïŒ
å¹ããšããçµæã«ãªã£ã
ãšããã¹ããŒãªãŒãæ³å®ã§ããã®ã§ãã
ãããè£ä»ãããããªè«æãåºãŠããŸãããã¡ããNEJMã®è«æã
https://www.nejm.org/doi/full/10.1056/nejmc2101927
ç°¡åã«èšããšã
ãã¯ã¯ãã³æ¥çš®è ã®ã³ããææç¶æ³ã远跡調æ»ããããæ¥çš®åŸ2é±éã®éã«ææãéäžããŠããã
ãšãããã®ã

ãããäžã§ã¯ã¯ã¯ãã³æ¥çš®åŸã®ãéã®2é±éããšåŒã°ããæ³šæãä¿ãããŠããŸããã
ãããã§åãããŠãããã®ãã¯ã¯ãã³æ¥çš®çŽåŸã®ææãâŠãå®ã¯natureã§ææãããããªã³ãçæžå°ãã«ãããã®ã ã£ãã®ãããããŸãããã
ã¡ãªã¿ã«æ¥æ¬ã§ã¯ãã¯ã¯ãã³æ¥çš®ã®çŽåŸããã³ããææå¢å ãçºçããŠããŸãããåæã«ç·æ»äº¡æ°å¢å ïŒè¶
éæ»äº¡çå¢å ïŒãèŠãããŠããŸãã

https://medicalfacts.info/infect.rb?c=Japan&from=2022-01-01&to=2022-12-29&new_vaccinations_smoothed_per_million=true&excess_mortality=true&two=true&l=ja&i=false
ã»åœæ°ã®8å²ã9å²ãã¯ã¯ãã³ãæã£ãã
ããâ
ã»ã¯ã¯ãã³æ¥çš®çŽåŸã¯ã»ãŒå
šå¡ãªã³ãçãæžå°ããã²ã©ããšãã«ã¯AIDSã¬ãã«ãŸã§å
ç«ãäœäžã
ããâ
ã»è¥ããŠå
æ°ãªäººãªãã³ããããã®ä»é¢šéªãŠã€ã«ã¹ãªã©ã®äžæçãªææã§çµããã
ã»ã§ããé«éœ¢ã®æ¹ã
ã®äžéšã¯ææããå埩ãããã®ãŸãŸã亡ããªãã«ãªãã
ãã®çµæããã®ã°ã©ãã®ãããªãç°æ¬¡å
ã®ãç·æ»äº¡ã»è¶
éæ»äº¡å¢å ããªã®ã§ã¯ãªãã®ããªâŠïŒ

ãã¡ãããããã§ç¢ºèšŒã«è³ãããã§ã¯ãããŸããããæ§ã ãªè«æãçŸå®ã®ããŒã¿ãèŠããšãç¶æ³èšŒæ ãšããŠã¯ããªãä¿¡é Œæ§ãé«ãã®ã§ã¯ãªãããšæããŸããïŒã¡ãªã¿ã«å»åŠã§ã¯æ±ºå®çãªèšŒæ ãšããã®ã¯æ®ã©åºãŠããŸãããåºãŠãããšæã£ããæ°å¹ŽåŸã«èŠãããªããŠããšãããããäžçã§ãããïŒ
以äžããã¯ã¯ãã³æ¥çš®åŸäžé±éã¯AIDSã¬ãã«ãŸã§ãªã³ãçãæžå°ãããnatureè«æããã§ããïŒ
泚ïŒãã®èšäºã¯æãé圢åŒã§ãã
å»çã¯èª°ã«ã§ãå
¬å¹³ã«æäŸãããã¹ãã瀟äŒçå
±éè³æ¬ãã
ãšãã信念ãªã®ã§å»çæ
å ±ã¯åºæ¬çã«ç¡åã§æäŸããããŸãã
ã§ãæãéã¯å€§æè¿ïŒ
ãã€ãçæ§ã®æãéãã倧ããªãåæ°ãé ããŠãããŸãã
ããããšãããããŸãm(_ _)m
â æ°å

â å
容(ã¯ããã«ããæç²)â
2019幎ã«å§ãŸã£ãæ°åã³ãããŠã€ã«ã¹éšåã
å»çæ¥çãã¯ããè¡æ¿ãã¡ãã£ã¢ã«å
å°ããããã®éšåã¯ãæ®å¿µãªãããçµæžãå£ããã人ã
ã®çµãæã¡åãããèªæ®ºæ°ãå¢å ããããŠããŸã£ãã
ç§ã¯çµæžåŠéšåºèº«ã®å»åž«ãšããç«å Žããããã®ãããªéå°ãªææå¯Ÿçã«ãããã¡ãªãããæããŠããããããŠãããåé¡èŠããçºä¿¡ãç¶ããŠãããã ãããã®ãéå°ã«ã³ãããæããŠããŸã颚朮ãã¯2022幎ã«ãªã£ãŠãäŸç¶ãšããŠç¶ç¶ããŠããã
2022幎1æã®å
šåœé«æ ¡ãµãã«ãŒéžææš©ã®æºæ±ºåã§ã¯ãéžæ2äººã«æ°åã³ããéœæ§åå¿ãåºããšã®ããšã§é¢æ±ç¬¬äžé«æ ¡ãåºå ŽãèŸéããã
ãŸãã§ãã³ããã«ææããã瀟äŒã®è¿·æã»åä»è
ããšèšããã°ããã®å¯Ÿå¿ã ãææããŠããŸã£ãåœè©²çåŸã®æ°æã¡ãå¯ããã«äœãããã
ã³ããéšåãå§ãŸã£ãŠãã2幎ãçµã£ãŠããã®ã«âŠ
瀟äŒã®éå°åå¿ã¯åœåãšäœãå€ãã£ãŠããªãããã«æããã
ä»åŸããã®ãããªé¢šæœ®ãç¶ãã®ã§ããã°ããããããæ°ããçæŽ»æ§åŒããšãªã£ãŠç€ŸäŒã«å®çãæåã«ãªã£ãŠããŸãã®ã ããã
ç§ã¯ãããªãå®¶çãã®ãããªç掻ããææãæããŠäººãšã®çµãæ¥è§Šãæã¡åããããªç€ŸäŒãã絶察ã«åã©ããã¡ã«æ®ããããªãã
ãããªãããããªãæããæ¥ã
é«ãŸã£ãŠãããææ
¢ã§ããªããªã£ãã®ããæ¬æžãæžãããšæã£ããã£ããã ã
â ã¿ã€ãã«ã»å
容ã®éæ¿ãããæ°ã
ã®åºç瀟ããæžç±åãæããã¯ã©ãŠããã¡ã³ãã£ã³ã°ã«ããèªè²»åºçãšãªã£ãæ¬æžã
äžå€ã«ããŠç®æšé¡ãéæãããã®æ³šç®åºŠã¯å»çã«ãšã©ãŸãã人æã»ç€ŸäŒç§åŠã«ãåºãã£ãŠããã
ãâ
https://amzn.to/37nNQO5